Carasent: Back in Shape in 2024 – More to Come - Redeye

Redeye retains its positive view of Carasent following the Q4 report. Despite a somewhat softer Q4 report than expected and a softened outlook for H1 2025, we changed our Base Case driven by revised mid- and long-term assumptions.

Länk till analysen i sin helhet: https://www.redeye.se/research/1077967/carasent-back-in-shape-in-2024-more-to-come?utm_source=finwire&utm_medium=RSS